本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ZyVersa Therapeutics, Inc.

0.2005
+0.01055.53%
成交量:2.97萬
成交額:5,845.83
市值:162.33萬
市盈率:-0.05
高:0.2284
開:0.1900
低:0.1900
收:0.1900
52周最高:1.67
52周最低:0.1100
股本:809.59萬
流通股本:767.32萬
量比:3.00
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-4.1839
每股收益(LYR):-8.4803
淨資產收益率:-112.65%
總資產收益率:-40.85%
市淨率:-0.13
市盈率(LYR):-0.02

資料載入中...

2024/04/17

重要事件披露

Form 8-K - Current report
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/23

重要事件披露

Form 8-K - Current report
2023/12/11

重要事件披露

Form 8-K - Current report
2023/12/06

SEC問詢函

Form CORRESP - Correspondence
2023/12/06

SEC問詢函

Form CORRESP - Correspondence
2023/12/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/22

SEC問詢函

Form CORRESP - Correspondence
2023/11/22

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/18

重要事件披露

Form 8-K - Current report
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]